The Food and Drug Administration has approved a generic version of the birth control pill Yaz, despite thousands of lawsuits linking the pill with blood clots, pulmonary embolism, strokes and heart attacks in women.
The generic version, called Ventura, is marketed and sold by Watson Pharmaceuticals. Watson is claiming that Ventura can not only prevent pregnancy, but also treat moderate acne in women at least 14 years of age.
Bayer, the manufacturer of Yaz, was sent three different letters by the FDA in 2003, 2008, and 2009, warning the company about misleading consumers about the drug’s effective use for acne prevention and downplaying the serious side-effects that are possible when using it.
Drospirenone is the active drug in both the commercial and generic version of the pill, and is the chemical associated with the serious side-effects.
There are other birth control options that are just as effective as drospirenone-containing pills. Why has the FDA, instead of removing the dangerous drug from the market, instead allowed the entry of yet another dangerous pill?
The Edgar Law Firm asked a similar question last week. We wonder why as well.
Sarelson Law Firm – Miami litigation attorneys